Navigation Links
SyntheMed Announces FDA Clearance of SinusShield(TM)
Date:11/19/2008

ISELIN, N.J., Nov. 19 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD) announced today that it has received FDA 510(k) clearance to market SinusShield(TM), a bioresorbable membrane intended to prevent post-operative adhesions in nasal and sinus surgical procedures. There are approximately two million nasal and sinus procedures performed annually in the United States.

Robert P. Hickey, SyntheMed's President & CEO stated, "SinusShield represents an example of our strategy to capitalize on our proprietary polymer film technology in new surgical applications both in the United States and international markets." The company is in discussion with prospective partners with the distribution infrastructure to service the office-based and hospital outpatient sites where these procedures are performed.

About SinusShield(TM)

SinusShield is a bioresorbable polymer membrane indicated for use in patients undergoing nasal and sinus surgical procedures as a space-occupying stent to separate and prevent adhesions between mucosal surfaces. During surgical procedures involving the sinuses and sinus passages, it is common for surgeons to place silastic tubes or sheets in the sinus passages to prevent blockage caused by adhesion formation; however, these materials must often be removed in a second procedure. SinusShield is intended to prevent blockage and then biodegrade thereby eliminating the second procedure.

About SyntheMed, Inc.

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion products and other surgical implants based on its proprietary bioresorbable polymer technology. The company is developing a portfolio of anti-adhesion products led by REPEL-CV(R) Adhesion Barrier, an anti-adhesion product intended for use in open heart surgical procedures. REPEL-CV is currently marketed internationally and is
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
2. SyntheMed to Present at the Acumen BioFin Conference
3. SyntheMed Files Universal Shelf Registration
4. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
5. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
6. SyntheMed Completes $4.0 Million Equity Placement
7. SyntheMed Announces New Management Appointments
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 Two separate delegations of ... by Charm Sciences at its Andover, Massachusetts facility ... the US, the participants discussed international systems for ... and process verification, and received hands-on technical training ... the first visit to the United States for ...
(Date:10/31/2014)... The report "Dairy Alternative (Beverage) ... Flavored, Sweetened, Unsweetened), Channel (Supermarket, Health Store, Pharmacy, ... Forecast to 2018," defines and segments the dairy ... of revenue and volume for plant-based dairy alternative ... reach $14 Billion by 2018 with the Asia-Pacific ...
(Date:10/31/2014)... , Oct. 31, 2014  Tavistock Development Co. ... Tavistock Group, celebrated the groundbreaking of the GuideWell ... The 92,000-square-foot, three-story facility is ... Florida designed specifically for life sciences, ... heart of the 650-acre Lake Nona Medical City, ...
(Date:10/30/2014)...  Ardelyx, Inc. (NASDAQ: ARDX ), ... and metabolic diseases, today announced that it will ... November 6, 2014. Following the announcement, the Ardelyx ... and webcast at 4:30pm ET to review the ... The live webcast can be accessed ...
Breaking Biology Technology:Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 2GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 3Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2
... Medicine Labels for ... May 6 Summer is fast,approaching, bringing sunshine, vacation days, ... a peak in seasonal allergies and the,beginning of a busy ... Americans believe they will spend some time driving this Memorial,Day ...
... prevents wastage by saving the patient,s own whole blood, ... in a journal for,perfusionists, the health professionals who manage ... surgery, reports how Global Blood,Resources, online waste calculator can ... with the "cell washing" machines most commonly used,during heart ...
... of 60 Companies Selected to Participate at the "Facing ... Marking the Country,s 60th Birthday, JERUSALEM, Israel, May ... oral delivery systems,has been selected for the first annual ... of tomorrow" representing the,future face of Israel. The monumental ...
Cached Biology Technology:Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season 2Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season 3Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions 2Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions 3Israel's Prestigious President's Conference to Feature Oramed Pharmaceuticals' Revolutionary Oral Insulin Capsule 2
(Date:10/31/2014)... WCS study confirms that endangered musk deer still live ... sighting, Species targeted by poachers: Musk deer scent glands ... the October issue of the journal Oryx ... 60 years after its last confirmed sighting, a strange ... forested slopes of northeast Afghanistan according to a research ...
(Date:10/31/2014)... Planting trees and creating green space in cities is good ... ensure biodiversity in built environments, a University of Iowa study ... in an urban area in Iowa, and recorded the abundance ... while there were plenty of the trees, black cherry and ... insects, in this case fruit flies that feed on the ...
(Date:10/31/2014)... team have been studying the behavior of approximately ... for years. They observed that ravens slowly build ... playing. However, they also observed that these affiliative ... Although in about 50 % of the cases ... two affiliating ravens, intervening can be potentially risky ...
Breaking Biology News(10 mins):Strange, fanged deer persists in Afghanistan 2Green spaces don't ensure biodiversity in urban areas 2
... 22, 2011 Los Alamos National Laboratory scientists have won ... the "Oscars of Invention" by the Chicago Tribune, these ... the past year. The winning Laboratory technologies include a ... fluid for oil wells that shrinks when heated, and ...
... Concordians have received prestigious awards from the Natural Sciences ... Nadia Bhuiyan and Yves Glinas are the recipients of ... Bhuiyan, a professor in the Department of Mechanical and ... of Aerospace Design and Innovation, specializes in operations management ...
... athletic fields with sand has been used by turfgrass ... and healthy turf, and using porous sand allows the ... adequate drainage, even in heavy foot traffic. While ... municipalities, conversion to a sand-based system is expensive. Complete ...
Cached Biology News:Los Alamos National Laboratory earns 3 R&D 100 Awards 2Los Alamos National Laboratory earns 3 R&D 100 Awards 3Concordia research accelerated 2Optimal topdressing applications for athletic fields determined 2
... Human, Assay, 96 wells. ELISA.Specific for ... complexed MMP-3. No cross-reactivity with MMP-1, -2, ... for use with cell culture supernatant, serum, ... -15 to -30 C. Category: Drug ...
... from different human fetal normal tissues ... available upon request. Customers can ... whole set, and pay 70% of ... Dr. P Set products are for ...
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Self Closing Forceps...
Biology Products: